New Prescribing Instructions Tighten Use of Controversial Alzheimer's Drug

THURSDAY, July 8, 2021 — The U.S. Food and Drug Administration on Thursday issued new prescribing rules for the controversial Alzheimer’s medication Aduhelm that will likely limit its use.
When first approved a month ago, the FDA said Biogen’s…
Source: Topamax